NCT01781728View on ClinicalTrials.gov

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

March 1, 2021

Study Completion Date

June 1, 2024

Conditions
Pancreatic CancerPeriampullary Adenocarcinoma
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Stereotactic Body Radiation Therapy (SBRT) which included 5 consecutive fractions of 25 to 33 Gy, following 3 months of multiagent chemotherapy.

Trial Locations (1)

21231

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT01781728 - Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma | Biotech Hunter | Biotech Hunter